1887

Abstract

Rift Valley fever is a mosquito-borne zoonotic disease endemic to sub-Saharan Africa. Rift Valley fever virus (RVFV; genus , family ) causes high rates of abortion and fetal malformation in pregnant ruminants, and haemorrhagic fever, neurological disorders or blindness in humans. The MP-12 strain is a highly efficacious and safe live-attenuated vaccine candidate for both humans and ruminants. However, MP-12 lacks a marker to differentiate infected from vaccinated animals. In this study, we originally aimed to characterize the efficacy of a recombinant RVFV MP-12 strain encoding Toscana virus (TOSV) NSs gene in place of MP-12 NSs (rMP12-TOSNSs). TOSV NSs promotes the degradation of dsRNA-dependent protein kinase (PKR) and inhibits interferon-β gene up-regulation without suppressing host general transcription. Unexpectedly, rMP12-TOSNSs increased death in vaccinated outbred mice and inbred BALB/c or C57BL/6 mice. Immunohistochemistry showed diffusely positive viral antigens in the thalamus, hypothalamus and brainstem, including the medulla. No viral antigens were detected in spleen or liver, which is similar to the antigen distribution of moribund mice infected with MP-12. These results suggest that rMP12-TOSNSs retains neuroinvasiveness in mice. Our findings demonstrate that rMP12-TOSNSs causes neuroinvasion without any hepatic disease and will be useful for studying the neuroinvasion mechanism of RVFV and TOSV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.051250-0
2013-07-01
2019-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/94/7/1441.html?itemId=/content/journal/jgv/10.1099/vir.0.051250-0&mimeType=html&fmt=ahah

References

  1. Anderson G. W. Jr , Slone T. W. Jr , Peters C. J. . ( 1988; ). The gerbil, Meriones unguiculatus, a model for Rift Valley fever viral encephalitis. . Arch Virol 102:, 187–196. [CrossRef] [PubMed]
    [Google Scholar]
  2. Austin D. , Baer A. , Lundberg L. , Shafagati N. , Schoonmaker A. , Narayanan A. , Popova T. , Panthier J. J. , Kashanchi F. . & other authors ( 2012; ). p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production. . PLoS ONE 7:, e36327. [CrossRef] [PubMed]
    [Google Scholar]
  3. Baer A. , Austin D. , Narayanan A. , Popova T. , Kainulainen M. , Bailey C. , Kashanchi F. , Weber F. , Kehn-Hall K. . ( 2012; ). Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication. . J Biol Chem 287:, 7399–7410. [CrossRef] [PubMed]
    [Google Scholar]
  4. Billecocq A. , Gauliard N. , Le May N. , Elliott R. M. , Flick R. , Bouloy M. . ( 2008; ). RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. . Virology 378:, 377–384. [CrossRef] [PubMed]
    [Google Scholar]
  5. Bird B. H. , Albariño C. G. , Nichol S. T. . ( 2007; ). Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. . Virology 362:, 10–15. [CrossRef] [PubMed]
    [Google Scholar]
  6. Bouloy M. , Janzen C. , Vialat P. , Khun H. , Pavlovic J. , Huerre M. , Haller O. . ( 2001; ). Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. . J Virol 75:, 1371–1377. [CrossRef] [PubMed]
    [Google Scholar]
  7. Caplen H. , Peters C. J. , Bishop D. H. . ( 1985; ). Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. . J Gen Virol 66:, 2271–2277. [CrossRef] [PubMed]
    [Google Scholar]
  8. Cêtre-Sossah C. , Zeller H. , Grandadam M. , Caro V. , Pettinelli F. , Bouloy M. , Cardinale E. , Albina E. . ( 2012; ). Genome analysis of Rift Valley fever virus, Mayotte. . Emerg Infect Dis 18:, 969–971.[PubMed]
    [Google Scholar]
  9. Daubney R. , Hudson J. R. , Garnham P. C. . ( 1931; ). Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep cattle and man from east Africa. . J Pathol Bacteriol 34:, 545–579. [CrossRef]
    [Google Scholar]
  10. Fernandez J. C. , Billecocq A. , Durand J. P. , Cêtre-Sossah C. , Cardinale E. , Marianneau P. , Pépin M. , Tordo N. , Bouloy M. . ( 2012; ). The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus. . Clin Vaccine Immunol 19:, 5–10. [CrossRef] [PubMed]
    [Google Scholar]
  11. Gale M. Jr , Tan S. L. , Katze M. G. . ( 2000; ). Translational control of viral gene expression in eukaryotes. . Microbiol Mol Biol Rev 64:, 239–280. [CrossRef] [PubMed]
    [Google Scholar]
  12. Gori Savellini G. , Weber F. , Terrosi C. , Habjan M. , Martorelli B. , Cusi M. G. . ( 2011; ). Toscana virus induces interferon although its NSs protein reveals antagonistic activity. . J Gen Virol 92:, 71–79. [CrossRef] [PubMed]
    [Google Scholar]
  13. Grobbelaar A. A. , Weyer J. , Leman P. A. , Kemp A. , Paweska J. T. , Swanepoel R. . ( 2011; ). Molecular epidemiology of Rift Valley fever virus. . Emerg Infect Dis 17:, 2270–2276. [CrossRef] [PubMed]
    [Google Scholar]
  14. Habjan M. , Pichlmair A. , Elliott R. M. , Overby A. K. , Glatter T. , Gstaiger M. , Superti-Furga G. , Unger H. , Weber F. . ( 2009; ). NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. . J Virol 83:, 4365–4375. [CrossRef] [PubMed]
    [Google Scholar]
  15. Ikegami T. . ( 2012; ). Molecular biology and genetic diversity of Rift Valley fever virus. . Antiviral Res 95:, 293–310. [CrossRef] [PubMed]
    [Google Scholar]
  16. Ikegami T. , Makino S. . ( 2011; ). The pathogenesis of Rift Valley fever. . Viruses 3:, 493–519. [CrossRef] [PubMed]
    [Google Scholar]
  17. Ikegami T. , Won S. , Peters C. J. , Makino S. . ( 2006; ). Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. . J Virol 80:, 2933–2940. [CrossRef] [PubMed]
    [Google Scholar]
  18. Ikegami T. , Narayanan K. , Won S. , Kamitani W. , Peters C. J. , Makino S. . ( 2009; ). Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. . PLoS Pathog 5:, e1000287. [CrossRef] [PubMed]
    [Google Scholar]
  19. Ito N. , Takayama-Ito M. , Yamada K. , Hosokawa J. , Sugiyama M. , Minamoto N. . ( 2003; ). Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. . Microbiol Immunol 47:, 613–617.[PubMed] [CrossRef]
    [Google Scholar]
  20. Kalveram B. , Ikegami T. . ( 2013; ). Toscana Virus NSs Protein Promotes Degradation of Double-Stranded RNA-Dependent Protein Kinase. . J Virol 87:, 3710–3718. [CrossRef] [PubMed]
    [Google Scholar]
  21. Kalveram B. , Lihoradova O. , Ikegami T. . ( 2011a; ). NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. . J Virol 85:, 6234–6243. [CrossRef] [PubMed]
    [Google Scholar]
  22. Kalveram B. , Lihoradova O. , Indran S. V. , Ikegami T. . ( 2011b; ). Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy. . J Vis Exp 57:, e3400. [CrossRef] [PubMed]
    [Google Scholar]
  23. Kalveram B. , Lihoradova O. , Indran S. V. , Lokugamage N. , Head J. A. , Ikegami T. . ( 2013; ). Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR. . Virology 435:, 415–424. [CrossRef] [PubMed]
    [Google Scholar]
  24. Le May N. , Dubaele S. , De Santis L. P. , Billecocq A. , Bouloy M. , Egly J. M. . ( 2004; ). TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. . Cell 116:, 541–550. [CrossRef] [PubMed]
    [Google Scholar]
  25. Le May N. , Mansuroglu Z. , Léger P. , Josse T. , Blot G. , Billecocq A. , Flick R. , Jacob Y. , Bonnefoy E. , Bouloy M. . ( 2008; ). A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. . PLoS Pathog 4:, e13. [CrossRef] [PubMed]
    [Google Scholar]
  26. Lihoradova O. , Kalveram B. , Indran S. V. , Lokugamage N. , Juelich T. L. , Hill T. E. , Tseng C. T. , Gong B. , Fukushi S. . & other authors ( 2012; ). The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine. . J Virol 86:, 7650–7661. [CrossRef] [PubMed]
    [Google Scholar]
  27. Linthicum K. J. , Davies F. G. , Kairo A. , Bailey C. L. . ( 1985; ). Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya. . J Hyg (Lond) 95:, 197–209. [CrossRef] [PubMed]
    [Google Scholar]
  28. Lokugamage N. , Freiberg A. N. , Morrill J. C. , Ikegami T. . ( 2012; ). Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains. . J Virol 86:, 13566–13575. [CrossRef] [PubMed]
    [Google Scholar]
  29. Mansuroglu Z. , Josse T. , Gilleron J. , Billecocq A. , Leger P. , Bouloy M. , Bonnefoy E. . ( 2010; ). Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. . J Virol 84:, 928–939. [CrossRef] [PubMed]
    [Google Scholar]
  30. McElroy A. K. , Albariño C. G. , Nichol S. T. . ( 2009; ). Development of a RVFV ELISA that can distinguish infected from vaccinated animals. . Virol J 6:, 125. [CrossRef] [PubMed]
    [Google Scholar]
  31. Morrill J. C. , Jennings G. B. , Caplen H. , Turell M. J. , Johnson A. J. , Peters C. J. . ( 1987; ). Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. . Am J Vet Res 48:, 1042–1047.[PubMed]
    [Google Scholar]
  32. Morrill J. C. , Carpenter L. , Taylor D. , Ramsburg H. H. , Quance J. , Peters C. J. . ( 1991; ). Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep. . Vaccine 9:, 35–41. [CrossRef] [PubMed]
    [Google Scholar]
  33. Morrill J. C. , Mebus C. A. , Peters C. J. . ( 1997a; ). Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. . Am J Vet Res 58:, 1104–1109.[PubMed]
    [Google Scholar]
  34. Morrill J. C. , Mebus C. A. , Peters C. J. . ( 1997b; ). Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. . Am J Vet Res 58:, 1110–1114.[PubMed]
    [Google Scholar]
  35. Morrill J. C. , Ikegami T. , Yoshikawa-Iwata N. , Lokugamage N. , Won S. , Terasaki K. , Zamoto-Niikura A. , Peters C. J. , Makino S. . ( 2010; ). Rapid accumulation of virulent Rift Valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA. . PLoS ONE 5:, e9986. [CrossRef] [PubMed]
    [Google Scholar]
  36. Morrill J. C. , Laughlin R. C. , Lokugamage N. , Pugh R. , Sbrana E. , Weise W. J. , Adams L. G. , Makino S. , Peters C. J. . ( 2013; ). Safety and immunogenicity of recombinant Rift Valley Fever MP-12 vaccine candidates in sheep. . Vaccine 31:, 559–565. [CrossRef] [PubMed]
    [Google Scholar]
  37. Pepin M. , Bouloy M. , Bird B. H. , Kemp A. , Paweska J. . ( 2010; ). Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. . Vet Res 41:, 61. [CrossRef] [PubMed]
    [Google Scholar]
  38. Schmaljohn C. , Nichol S. T. . ( 2007; ). Bunyaviridae . . In Fields Virology, , 5th edn., pp. 1741–1789 . Edited by Knipe D. M. , Howley P. M. , Griffin D. E. , Lamb R. A. , Martin M. A. , Roizman B. , Straus. S. E. . Philadelphia, PA:: Lipincott, Williams & Wilkins;.
    [Google Scholar]
  39. Smith D. R. , Steele K. E. , Shamblin J. , Honko A. , Johnson J. , Reed C. , Kennedy M. , Chapman J. L. , Hensley L. E. . ( 2010; ). The pathogenesis of Rift Valley fever virus in the mouse model. . Virology 407:, 256–267. [CrossRef] [PubMed]
    [Google Scholar]
  40. Swanepoel R. , Coetzer J. A. W. . ( 2004; ). Rift Valley fever. . In Infectious Diseases of Livestock with Special Reference to Southern Africa, , 2nd edn., pp. 1037–1070. Edited by Coetzer J. A. W. , Tustin R. C. . . Cape Town, South Africa:: Oxford University Press;.
    [Google Scholar]
  41. Tesh R. B. . ( 1988; ). The genus Phlebovirus and its vectors. . Annu Rev Entomol 33:, 169–181. [CrossRef] [PubMed]
    [Google Scholar]
  42. Wang T. , Town T. , Alexopoulou L. , Anderson J. F. , Fikrig E. , Flavell R. A. . ( 2004; ). Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. . Nat Med 10:, 1366–1373. [CrossRef] [PubMed]
    [Google Scholar]
  43. Xu F. , Chen H. , Travassos da Rosa A. P. , Tesh R. B. , Xiao S. Y. . ( 2007; ). Phylogenetic relationships among sandfly fever group viruses (Phlebovirus: Bunyaviridae) based on the small genome segment. . J Gen Virol 88:, 2312–2319. [CrossRef] [PubMed]
    [Google Scholar]
  44. Yang Y. L. , Reis L. F. , Pavlovic J. , Aguzzi A. , Schäfer R. , Kumar A. , Williams B. R. , Aguet M. , Weissmann C. . ( 1995; ). Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. . EMBO J 14:, 6095–6106.[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.051250-0
Loading
/content/journal/jgv/10.1099/vir.0.051250-0
Loading

Data & Media loading...

Supplements

Supplementary material 

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error